Ranibizumab treat and extend for neovascular age-related macular degeneration (AMD) - One-year outcomes

被引：0
|
作者：
Trivedi, Dipti [1 ]
Alfaqawi, Fadi [1 ]
Lip, Peck Lin [1 ]
Mushtaq, Bushra [1 ]
Chavan, Randhir [1 ]
机构：
[1] Birmingham & Midland Eye Ctr, Birmingham, W Midlands, England
来源：
EYE | 2018年 / 32卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
RF10
引用
收藏
页码：20 / 23
页数：4
相关论文
共 50 条
  • [31] Tolerating Subretinal Fluid in the Treatment of Neovascular Age-Related Macular Degeneration With Ranibizumab Using a Treat and Extend Regimen
    Arnold, Jennifer
    Markey, Caroline
    McAllister, Ian
    Gillies, Mark C.
    Hunyor, Alex
    Guymer, Robyn H.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2018, 59 (09)
  • [32] INTRAVITREAL AFLIBERCEPT IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION WITH LIMITED RESPONSE TO RANIBIZUMAB A Treat-and-Extend Trial
    Hatz, Katja
    Prunte, Christian
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2017, 37 (06): : 1185 - 1192
  • [33] Twelve-month outcomes of aflibercept versus ranibizumab for neovascular age-related macular degeneration (AMD)
    Almuhtaseb, Hussein
    Michaels, Luke
    Vardarinos, Thanos
    Lotery, Andrew J.
    EYE, 2018, 32 (11) : 8 - 10
  • [34] One-year outcomes with ranibizumab in treatment naive patients with neovascular age-related macular degeneration: an interim analysis from the LUMINOUS™ study
    Brand, Christopher
    Lacey, Sue
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2016, 57 (12)
  • [35] One-year results of treat-and-extend regimen with intravitreal faricimab for treatment-naïve neovascular age-related macular degeneration
    Hidetaka Matsumoto
    Junki Hoshino
    Kosuke Nakamura
    Hideo Akiyama
    Japanese Journal of Ophthalmology, 2024, 68 : 83 - 90
  • [36] TWO YEAR OUTCOMES OF "TREAT AND EXTEND" INTRAVITREAL THERAPY USING AFLIBERCEPT PREFERENTIALLY FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION
    Barthelmes, Daniel
    Vuong Nguyen
    Daien, Vincent
    Campain, Anna
    Walton, Richard
    Guymer, Robyn
    Morlet, Nigel
    Hunyor, Alex P.
    Essex, Rohan W.
    Arnold, Jennifer J.
    Gillies, Mark C.
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2018, 38 (01): : 20 - 28
  • [37] One-year results of treat-and-extend regimen with intravitreal faricimab for treatment-naïve neovascular age-related macular degeneration
    Matsumoto, Hidetaka
    Hoshino, Junki
    Nakamura, Kosuke
    Akiyama, Hideo
    JAPANESE JOURNAL OF OPHTHALMOLOGY, 2024, 68 (02) : 83 - 90
  • [38] One-Year Outcomes of Faricimab Treatment for Aflibercept-Resistant Neovascular Age-Related Macular Degeneration
    Rush, Ryan B.
    CLINICAL OPHTHALMOLOGY, 2023, 17 : 2201 - 2208
  • [39] One-Year Outcomes of Intravitreal Conbercept for Treatment-Resistant Neovascular Age-Related Macular Degeneration
    Li, Xun
    Zhang, Yun
    Zhang, Zirong
    Xu, Yunyi
    Zhang, Meixia
    OPHTHALMIC RESEARCH, 2019, 62 (02) : 93 - 100
  • [40] One-Year Effectiveness Study of Intravitreous Ranibizumab in Wet (Neovascular) Age-Related Macular Degeneration: A Meta-Analysis
    Guo, Michael Y.
    Etminan, Mahyar
    Cheng, Jasmine Z.
    Zafari, Zafar
    Maberley, David A. L.
    PHARMACOTHERAPY, 2018, 38 (02): : 197 - 204
12345